Ju-Hee Lee Selected Research

Hypertension (High Blood Pressure)

1/2024	Efficacy and safety of combination therapy with telmisartan, rosuvastatin, and ezetimibe in patients with dyslipidemia and hypertension: A randomized, double-blind, multicenter, therapeutic confirmatory, phase III clinical trial.
2/2021	Antihypertensive Drugs and the Risk of Cancer: A Nationwide Cohort Study.
1/2021	Disparities in Mortality and Cardiovascular Events by Income and Blood Pressure Levels Among Patients With Hypertension in South Korea.
1/2021	Office blood pressure threshold of 130/80 mmHg better predicts uncontrolled out-of-office blood pressure in apparent treatment-resistant hypertension.
1/2021	Office Blood Pressure Range and Cardiovascular Events in Patients With Hypertension: A Nationwide Cohort Study in South Korea.
1/2018	Telmisartan generates ROS-dependent upregulation of death receptor 5 to sensitize TRAIL in lung cancer via inhibition of autophagy flux.
12/2011	Morning hypertension in treated hypertensives: baseline characteristics and clinical implications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ju-Hee Lee Research Topics

Disease

41	Neoplasms (Cancer) 05/2022 - 12/2006
26	Stomach Neoplasms (Stomach Cancer) 08/2021 - 08/2010
14	Mitochondrial Diseases (Mitochondrial Disease) 12/2018 - 11/2012
11	Hypoxia (Hypoxemia) 01/2019 - 07/2008
8	Psoriasis (Pustulosis Palmaris et Plantaris) 05/2024 - 08/2012
7	Hypertension (High Blood Pressure) 01/2024 - 12/2011
7	Breast Neoplasms (Breast Cancer) 11/2023 - 01/2012
7	Neoplasm Metastasis (Metastasis) 03/2019 - 06/2011
6	Inflammation (Inflammations) 03/2019 - 01/2014
6	Prion Diseases (Transmissible Spongiform Encephalopathies) 05/2016 - 11/2012
5	Heart Failure 10/2023 - 01/2018
5	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 07/2008
5	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2016 - 11/2012
4	Skin Diseases (Skin Disease) 09/2020 - 01/2016
3	Myocardial Infarction 04/2024 - 01/2021
3	Obesity 06/2023 - 01/2018
3	Muscular Atrophy (Muscle Atrophy) 06/2023 - 11/2017
3	Necrosis 05/2022 - 02/2009
3	Colorectal Neoplasms (Colorectal Cancer) 03/2020 - 01/2019
3	Body Weight (Weight, Body) 01/2019 - 02/2011
3	Lung Neoplasms (Lung Cancer) 01/2018 - 07/2008
3	Liver Cirrhosis (Hepatic Cirrhosis) 12/2014 - 02/2011
3	Scrapie 08/2014 - 02/2013
2	Dyslipidemias (Dyslipidemia) 01/2024 - 10/2013
2	Fever (Fevers) 06/2023 - 01/2017
2	COVID-19 09/2022 - 05/2022
2	Myocarditis (Carditis) 05/2022 - 05/2022
2	Stroke (Strokes) 01/2022 - 01/2021
2	Macular Degeneration (Age-Related Maculopathy) 02/2020 - 01/2019
2	Fatty Liver 06/2018 - 04/2015
2	Cardiotoxicity 03/2018 - 01/2016
2	Experimental Melanoma 08/2015 - 03/2009
2	Adenocarcinoma 04/2014 - 01/2014
2	Lymphatic Metastasis 01/2013 - 04/2011
1	Death (Near-Death Experience) 04/2024

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 10/2022 - 12/2006
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 07/2008
8	Prion ProteinsIBA 01/2019 - 02/2013
6	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2018 - 08/2010
5	Messenger RNA (mRNA)IBA 05/2022 - 07/2008
5	Antineoplastic Agents (Antineoplastics)IBA 11/2017 - 12/2011
5	Histone Deacetylase InhibitorsIBA 02/2017 - 12/2006
4	Imiquimod (Aldara)FDA LinkGeneric 09/2020 - 10/2016
4	Histone Deacetylases (Histone Deacetylase)IBA 01/2017 - 01/2008
3	omega-Chloroacetophenone (Mace)IBA 04/2024 - 01/2021
3	Dexamethasone (Maxidex)FDA LinkGeneric 06/2023 - 11/2017
3	CytokinesIBA 09/2022 - 01/2021
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2022 - 07/2014
3	Biomarkers (Surrogate Marker)IBA 04/2022 - 03/2018
3	DiureticsIBA 02/2021 - 01/2018
3	Therapeutic UsesIBA 01/2021 - 01/2019
3	Phosphotransferases (Kinase)IBA 09/2019 - 01/2012
3	AMP-Activated Protein KinasesIBA 06/2018 - 01/2017
3	Caspase 3 (Caspase-3)IBA 03/2018 - 10/2010
3	LigandsIBA 03/2017 - 07/2014
3	MelatoninIBA 03/2016 - 07/2014
3	Protein Isoforms (Isoforms)IBA 08/2014 - 05/2012
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2013 - 05/2012
3	Thymidylate SynthaseIBA 07/2011 - 12/2006
2	calcipotriene (calcipotriol)FDA LinkGeneric 05/2024 - 11/2022
2	AerosolsIBA 05/2024 - 11/2022
2	betamethasone-17,21-dipropionate (betamethasone dipropionate)FDA LinkGeneric 05/2024 - 11/2022
2	Immunoglobulin A (IgA)IBA 05/2024 - 11/2022
2	Ezetimibe (Zetia)FDA Link 01/2024 - 10/2013
2	CholesterolIBA 01/2024 - 01/2021
2	Telmisartan (Micardis)FDA Link 01/2024 - 01/2018
2	Trastuzumab (Herceptin)FDA Link 11/2023 - 11/2017
2	EnzymesIBA 05/2022 - 01/2011
2	LipidsIBA 10/2021 - 01/2019
2	Antihypertensive Agents (Antihypertensives)IBA 02/2021 - 01/2021
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2021 - 01/2021
2	Angiotensin Receptor AntagonistsIBA 02/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2011
2	Ophthalmic Solutions (Eye Drops)IBA 02/2020 - 01/2019
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 03/2019 - 11/2017
2	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 12/2006
2	puag-haadIBA 06/2018 - 02/2016
2	Metformin (Glucophage)FDA LinkGeneric 03/2017 - 04/2016
2	sauchinoneIBA 01/2017 - 12/2014
2	Atorvastatin (Lipitor)FDA Link 01/2017 - 10/2013
2	beta-thujaplicinIBA 01/2017 - 05/2016
2	tryptanthrineIBA 01/2017 - 01/2014
2	Sirtuin 1IBA 01/2017 - 01/2016
2	PrionsIBA 05/2016 - 02/2013
2	ThioredoxinsIBA 01/2012 - 08/2010
2	Vorinostat FDA Link 01/2012 - 12/2011
2	deguelinIBA 10/2010 - 07/2008
1	Hemoglobins (Hemoglobin)IBA 04/2024
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 04/2024
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2024
1	human ERBB2 proteinIBA 11/2023
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 10/2023

Therapy/Procedure

21	Gastrectomy 06/2023 - 12/2010
9	Therapeutics 01/2024 - 12/2010
6	Lymph Node Excision (Lymph Node Dissection) 04/2014 - 08/2012
4	Drug Therapy (Chemotherapy) 03/2018 - 10/2010
3	Length of Stay 10/2022 - 10/2013
3	Oral Administration 01/2019 - 05/2012
1	Patient Readmission 04/2024
1	Glycemic Control 04/2024